» Articles » PMID: 36913352

Is There a "price That's Right" for At-home COVID Tests?

Overview
Journal PLoS One
Date 2023 Mar 13
PMID 36913352
Authors
Affiliations
Soon will be listed here.
Abstract

The COVID-19 pandemic has impacted the daily lives of individuals across the world as multiple variants continue introducing new complexities. In December 2021, which is when we conducted our study, pressure to resume the normalcy of daily life was mounting as a new variant, Omicron, was rapidly spreading. A variety of at-home tests detecting SARS-CoV-2, known to the general public as "COVID tests," were available for consumers to purchase. In this study, we conducted conjoint analysis utilizing an internet-based survey by presenting consumers (n = 583) with 12 different hypothetical at-home COVID test concepts that varied on five attributes (price, accuracy, time, where-to-buy, and method). Price was identified as the most important attribute, because participants were very price sensitive. Quick turnaround time and high accuracy were also identified as important. Additionally, although 64% of respondents were willing to take an at-home COVID test, only 22% reported they had previously taken the test. On December 21, 2021, President Biden announced the U.S. government would purchase 500 million at-home rapid tests and distribute them for free to Americans. Given the importance of price to participants, this policy of providing free at-home COVID tests was directionally appropriate.

Citing Articles

A decade of clinical microbiology: top 10 advances in 10 years: what every infection preventionist and antimicrobial steward should know.

Jhaveri T, Weiss Z, Winkler M, Pyden A, Basu S, Pecora N Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e8.

PMID: 38415089 PMC: 10897726. DOI: 10.1017/ash.2024.10.

References
1.
Phillips K, Maddala T, Reed Johnson F . Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res. 2003; 37(6):1681-705. PMC: 1464051. DOI: 10.1111/1475-6773.01115. View

2.
Lee S, Brooks R, Bolan R, Flynn R . Assessing willingness to test for HIV among men who have sex with men using conjoint analysis, evidence for uptake of the FDA-approved at-home HIV test. AIDS Care. 2013; 25(12):1592-8. PMC: 3751974. DOI: 10.1080/09540121.2013.793272. View

3.
Simoni J, Tapia K, Lee S, Graham S, Beima-Sofie K, Mohamed Z . A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S. AIDS Behav. 2019; 24(4):1226-1236. PMC: 7085450. DOI: 10.1007/s10461-019-02701-7. View

4.
Schieffer R, Bryndza Tfaily E, DAquila R, Greene G, Carballo-Dieguez A, Giguere R . Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-Exposure Prophylaxis for HIV. AIDS Res Hum Retroviruses. 2021; 38(4):336-345. PMC: 9048179. DOI: 10.1089/AID.2021.0075. View